Using a rat stroke model, the team around Jia LI from Shanghai Jiaotong University School of Medicine found that when embryonic stemm cells derived from neural progenitor cells where co-transplanted with blood progenitor cells (ESC-VPCs), a more effective treatment of stroke symptoms was possible.

Nikkei Biotech news release, June 19, 2014

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny